Physician profile
Matthew Gilbert
NPI 1538695374
$350.92
in general payments reported to CMS, 2019-2025
9 companies · $81.36 in 2025
The $81.36 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.23 · 2020: $74.41 · 2022: $136 · 2023: $39.40 · 2025: $81.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $74.41 | 2020 | |
| Bioventus LLC | $73.68 | 2022-2025 | Durolane, Durolane |
| Astrazeneca Pharmaceuticals Lp | $47.86 | 2022 | |
| Teleflex LLC | $40.96 | 2022 | |
| Depuy Synthes Sales INC. | $30.02 | 2025 | Orthovisc, Monovisc |
| Vericel Corporation | $25.77 | 2022 | |
| Kerecis Limited | $21.26 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pfizer INC. | $20.23 | 2019 | |
| Smith+Nephew, INC. | $16.73 | 2025 | Coblation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.